σ2-receptor ligand-mediated inhibition of inwardly rectifying K+ channels in the heart

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 1, 2007, Pages 341-350

  Monassier, Laurent ^a   Manoury, Boris ^c   Bellocq, Chloé ^c   Weissenburger, Jacques ^b   Greney, Hugues ^a   Zimmermann, Diane ^a   Ehrhardt, Jean Daniel ^a   Jaillon, Patrice ^b   Baró, Isabelle ^c   Bousquet, Pascal ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; ALPHA 1 ADRENERGIC RECEPTOR; ANTIARRHYTHMIC AGENT; IFENPRODIL; INWARDLY RECTIFYING POTASSIUM CHANNEL; LIGAND; LNP 250A; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OPIATE AGONIST; OPIATE ANTAGONIST; PHENYLEPHRINE; POTASSIUM CHANNEL HERG; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; SM 21; THREO 8 [1 (4 HYDROXYPHENYL) 1 HYDROXYPROPAN 2 YL] 1 PHENYL 1,3,8 TRIAZASPIRO[4,5]DECAN 4 ONE; THREO IFENPRODIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL STRAIN COS7; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HEART; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; MALE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PURKINJE FIBER; RABBIT;

EID: 34250767747     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.122044     Document Type: Article

References (40)

1. Adamantidis MM, Lacroix DL, Caron JF, and Dupuis BA (1995) Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance. J Cardiovasc Pharmacol 26:319-327.
2. Aydar E, Palmer CP, Klyachko VA, and Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34:399-410.
3. Carlsson L, Almgren O, and Duker G (1990) QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions. J Cardiovasc Pharmacol 16:276-285.
4. Carter C, Rivy JP, and Scatton B (1989) Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor. Eur J Pharmacol 164:611-612.
5. Chenard BL, Shalaby IA, Koe BK, Ronau RT, Butler TW, Prochniak MA, Schmidt AW, and Fox CB (1991) Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. J Med Chem 34:3085-3090.
6. Décret 2001-464 (2001) Décret no 2001-464 du 29 mai 2001 modifiant le décret 87-848 du 19 octubre 1987 pris pour l'application de l'article 454 du code pénal et du troisième aliǹéa de l'article 276 du code rural et relatif aux expériences pratiquées sur les animaux. J Official République Française 125:8682.
7. 3H]1,3-di(2-tolyl) guanidine-defined sigma recognition sites. Life Sci 49:PL135- PL139.
8. 3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations. Eur J Pharmacol 209:245-248.
9. 2+ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 269:1300-1309.
10. 3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur J Pharmacol 430:147-148.
11. Ganapathy ME, Prasad PD, Huang W, Seth P, Leibach FH, and Ganapathy V (1999) Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 289:251-260.
12. Ghelardini C, Galeotti N, and Bartolini A (2000) Pharmacological identification of SM-21, the novel sigma(2) antagonist. Pharmacol Biochem Behav 67:659-662.
13. Hashimoto K and London ED (1995) Interactions of erythro- ifenprodil, threoifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of sigma receptors. Eur J Pharmacol 273:307-310.
14. 3H]ifenprodil binding in rat brain. Eur J Pharmacol 266:67-77.
15. 2+ movement in isolated canine saphenous veins. Arch Int Pharmacodyn Ther 292:112-121.
16. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
17. + channel of class III antiarrhythmic drugs? Eur J Pharmacol 241:111-116.
18. + channels by ifenprodil. Neuropsychopharmacology 31:516-524.
19. Kriwisky M, Perry GY, Tarchitsky D, Gutman Y, and Kishon Y (1990) Haloperidol-induced torsades de pointes. Chest 98:482-484.
20. Lawrence CL, Pollard CE, Hammond TG, and Valentin JP (2005) Nonclinical proarrhythmia models: predicting Torsades de Pointes. J Pharmacol Toxicol Methods 52:46-59.
21. + channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol 526:527-539.
22. Mach RH, Wu L, West T, Whirrett BR, and Childers SR (1999) The analgesic tropane analogue (+/-)-SM 21 has a high affinity for σ2 receptors. Life Sci 64:PL131-137.
23. Martin WR, Eades CG, Thompson JA, Huppler RE, and Gilbert PE (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphinedependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532.
24. Mohammad-Panah R, Demolombe S, Neyroud N, Guicheney P, Kyndt F, van den Hoff M, Baro I, and Escande D (1999) Mutations in a dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias. Am J Hum Genet 64:1015-1023.
25. Monassier L and Bousquet P (2002) Sigma receptors: from discovery to highlights of their implications in the cardiovascular system. Fundam Clin Pharmacol 16:1-8.
26. Monassier L, Tibirica E, Roegel JC, Mettauer B, Feldman J, and Bousquet P (1994) Prevention by NMDA receptor antagonists of the centrally-evoked increases of cardiac inotropic responses in rabbits. Br J Pharmacol 111:1347-1354.
27. + currents in rat locus coeruleus neurons in vitro. Eur J Pharmacol 361:157-163.
28. Novakova M, Ela C, Bowen WD, Hasin Y, and Eilam Y (1998) Highly selective sigma receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes. Eur J Pharmacol 353:315-327.
29. O'Brien JM, Rockwood RP, and Suh KI (1999) Haloperidol-induced torsade de pointes. Ann Pharmacother 33:1046-1050.
30. + channel. J Pharmacol Exp Ther 299:1007-1012.
31. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, and Taylor DP (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 13:85-86.
32. Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PK, Strang I, Sullivan AT, Wallis R, et al. (2003) Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 58:32-45.
33. 3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci U S A 81:5618-5621.
34. Valenzuela C, Delpon E, Franqueza L, Gay P, Perez O, Tamargo J, and Snyders DJ (1996) Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels. Circulation 94:562-570.
35. Vaupel DB (1983) Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. Eur J Pharmacol 92:269-274.
36. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, et al. (1988) The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22:447-455.
37. Wang Z, Fermini B, and Nattel S (1994) Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 28:1540-1546.
38. + channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors. J Physiol 517:391-406.
39. + channel, erg. Circ Res 80:261-268.
40. Zhang H and Cuevas J (2005) σ-Receptor activation blocks potassium channels and depresses neuroexcitability in rat intracardiac neurons. J Pharmacol Exp Ther 313:1387-1396.